Neuroleptic malignant syndrome induced by metoclopramide in an infant with Freeman-Sheldon syndrome [22]

Anesthesia and Analgesia

Volumn 103, Issue 3, 2006, Pages 786-787

  Stein, Mark H ^a   Sorscher, Michelle ^a   Caroff, Stanley N ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; HALOPERIDOL; METOCLOPRAMIDE; PROCHLORPERAZINE; DOPAMINE RECEPTOR BLOCKING AGENT;

CASE REPORT; CLINICAL FEATURE; DISEASE PREDISPOSITION; FEMALE; FEVER; FREEMAN SHELDON SYNDROME; HUMAN; INFANT; LETTER; LUNG INFILTRATE; NEUROLEPTIC MALIGNANT SYNDROME; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; RARE DISEASE; REFLUX ESOPHAGITIS; RISK FACTOR; THORAX RADIOGRAPHY; VOMITING; MULTIPLE MALFORMATION SYNDROME; SYNDROME;

ABNORMALITIES, MULTIPLE; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; INFANT; METOCLOPRAMIDE; NEUROLEPTIC MALIGNANT SYNDROME; RISK FACTORS; SYNDROME;

EID: 33749059415     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000227135.46049.B7     Document Type: Letter

References (14)

1. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993;77:185-202.
2. Silva RR, Munoz DM, Alpert M, et al. Neuroleptic malignant syndrome in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999;38:187-94.
3. Brower RD, Dreyer CF, Kent TA. Neuroleptic malignant syndrome in a child treated with metoclopramide for chemotherapy-related nausea. J Child Neurology 1989;4:230-2.
4. Moore A, O'Donahue NV, Monaghan H. Neuroleptic malignant syndrome. Arch Dis Childhood 1986;61:793-5.
5. Muniz AE. Prochlorperazine-induced extra pyramidal effects mimicking meningitis in a child. So Med J 2000;93:629-30.
6. Edwards MSB. Neuroleptic malignant syndrome. Pediatrics 1991;88:1074.
7. Shaw A, Matthews EE. Postoperative neuroleptic malignant syndrome. Anaesthesia 1995;50:246-7.
8. Casteels-Van Daele M, Van Geet C, Wouters C, Eggermont E. Reye syndrome revisited: a descriptive term covering a group of heterogeneous disorders. Eur J Pediatr 2000;159:641-8.
9. Sauk JJ Jr., Delaney JR, Reaume C, et al. Electromyography of oral-facial musculature in craniocarpaltarsal dysplasia (Freeman-Sheldon syndrome). Clin Genet 1974;6:132-7.
10. Vanek J, Janda J, Amblevora V, Losan F. Freeman-Sheldon syndrome: a disorder of congenital myopathic origin? J Med Genet 1986;23:231-6.
11. Laishley RS, Roy WL. Freeman-Sheldon syndrome: report of three cases and the anaesthetic implications. Can Anaesth Soc J 1986;33:388-3.
12. Jones R, Dolcourt JL. Muscle rigidity following halothane anesthesia in two patients with Freeman-Sheldon syndrome. Anesthesiology 1992;77:599-600.
13. Jones R, Dolcourt JL. Anesthesia for children with Freeman-Sheldon syndrome. Anesthesiology 1993;78:408.
14. Caroff SN, Rosenberg H, Mann SC, et al. Neuroleptic malignant syndrome in the perioperative setting. Am J Anesthesiol 2001;28:387-93.